Vascular cognitive impairment in dementia

Maturitas. 2014 Oct;79(2):220-6. doi: 10.1016/j.maturitas.2014.06.004. Epub 2014 Jun 14.

Abstract

Vascular risk factors and cerebrovascular disease are common causes of dementia. Shared risk factors for vascular dementia and Alzheimer's disease, as well as frequent coexistence of these pathologies in cognitively impaired older people, suggests convergence of the aetiology, prevention and management of the commonest dementias affecting older people. In light of this understanding, the cognitive impairment associated with cerebrovascular disease is an increasingly important and recognised area of the medicine of older people. Although the incidence of cerebrovascular events is declining in many populations, the overall burden associated with brain vascular disease will continue to increase associated with population ageing. A spectrum of cognitive disorders related to cerebrovascular disease is now recognised. Cerebrovascular disease in older people is associated with specific clinical and imaging findings. Although prevention remains the cornerstone of management, the diagnosis of brain vascular disease is important because of the potential to improve clinical outcomes through clear diagnosis, enhanced control of risk factors, lifestyle interventions and secondary prevention. Specific pharmacological intervention may also be indicated for some patients with cognitive impairment and cerebrovascular disease. However the evidence base to guide intervention remains relatively sparse.

Keywords: Brain ischaemia; Cerebral infarction; Cerebrovascular disorders; Dementia; Vascular.

Publication types

  • Review

MeSH terms

  • Alzheimer Disease / epidemiology
  • Alzheimer Disease / prevention & control*
  • Alzheimer Disease / psychology
  • Cerebral Infarction / epidemiology
  • Cerebral Infarction / prevention & control*
  • Cerebral Infarction / psychology
  • Cerebrovascular Disorders / epidemiology
  • Cerebrovascular Disorders / prevention & control
  • Cerebrovascular Disorders / psychology
  • Cognition Disorders / epidemiology
  • Cognition Disorders / prevention & control*
  • Cognition Disorders / psychology
  • Dementia, Vascular / epidemiology
  • Dementia, Vascular / prevention & control*
  • Dementia, Vascular / psychology
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Hypercholesterolemia / drug therapy
  • Hypercholesterolemia / epidemiology
  • Risk Factors
  • Risk Reduction Behavior
  • Secondary Prevention

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors